Joint Health Protocol

Support comfortable movement with evidence-based nutrients, botanicals, and daily habits that reduce pain, protect cartilage, and improve joint mobility.

Joint Health & Mobility Support Overview

Joint pain and stiffness are increasingly common, with osteoarthritis (OA) affecting nearly 1 in 6 adults—most often the hips, knees, and hands. OA involves the breakdown of cartilage, meniscal tissue, and joint linings, and may be worsened by age, excess weight, prior injury, hormonal shifts, and metabolic issues such as diabetes or hypertension.

Conventional care often focuses on symptom relief (NSAIDs, corticosteroid injections, exercise therapy, bracing). At Kaizen Health, we complement these with integrative strategies—targeted nutrition, botanical anti-inflammatories, and movement-based therapies—to reduce pain, improve function, and protect joint integrity.


🌱 Evidence-Based Nutrients & Botanicals

Glucosamine & Chondroitin

Typical dose: 1,500 mg glucosamine sulfate + 800–1,200 mg chondroitin sulfate daily for 6–24 months
Benefits include:
✅ Reduces pain and stiffness (comparable to celecoxib in some studies)
✅ Improves joint function (WOMAC) by ~50% in responders
✅ May slow cartilage loss and joint space narrowing
📚 Supported for long-term knee and hip OA management.

S-Adenosyl Methionine (SAMe)

Typical dose: 1,200 mg daily for ≥ 30 days
Benefits include:
✅ Joint pain relief comparable to certain NSAIDs
✅ Improved flexibility and function
✅ Fewer GI side effects than some conventional pain relievers
📚 Demonstrated reductions similar to celecoxib/naproxen in trials.

Turmeric (Curcuma longa)

Typical dose: 500 mg Meriva® or 400 mg curcumin, 2–4× daily for ≥ 30 days
Benefits include:
✅ Decreases pain and inflammation (ibuprofen-like effect in some studies)
✅ Improves joint mobility and lowers oxidative stress
✅ Generally gentler on the stomach than NSAIDs
📚 Bioavailable forms (e.g., Meriva®) show clinically meaningful pain relief.

Boswellia serrata

Typical dose: 338 mg standardized extract daily for 4+ weeks, or 150 mg boswellic acid with curcumin
Benefits include:
✅ Reduces pain, stiffness, and joint swelling
✅ Improves walking distance and function
✅ May lower CRP and other inflammatory markers
📚 Meta-analyses show relief within 4–8 weeks; may enhance curcumin.

Pycnogenol® (French Maritime Pine Bark)

Typical dose: 100–200 mg daily for ≥ 3 weeks
Benefits include:
✅ Antioxidant and microcirculatory support
✅ Improves mobility and can reduce medication need
✅ May decrease cartilage breakdown markers
📚 WOMAC pain reductions and lower NSAID use reported.


🌿 Lifestyle Foundations for Joint Health

True joint health goes beyond supplements—daily habits support mobility, flexibility, and long-term tissue integrity.

🏃‍♀️ 1. Move Daily—Mindfully

Low-impact activities (walking, swimming, cycling, yoga, tai chi) lubricate joints and strengthen stabilizing muscles.
💡 Aim for 150 minutes of moderate activity weekly, tailored to comfort.

🥗 2. Anti-Inflammatory Nutrition

Center meals on vegetables, berries, olive oil, fish, nuts; minimize refined sugars and processed oils.
Include omega-3-rich foods (salmon, flax, chia) to help lower inflammation.

💧 3. Hydration

Cartilage is largely water; dehydration increases stiffness.
💡 Target at least half your body weight (lbs) in ounces of water daily.

🧘‍♂️ 4. Stress Regulation

Chronic stress elevates inflammation and muscle tension.
Try breathwork, meditation, or gentle mobility breaks.

💤 5. Rest & Recovery

Sleep supports cartilage and connective tissue repair.
💡 Aim for 7–9 hours nightly with consistent sleep/wake times.


✨ The Kaizen Health Approach

At Kaizen Health, we blend conventional and integrative care to help you move freely and live with less pain. Our personalized plans include:

  • 🔬 Comprehensive evaluation of inflammation and nutrient status
  • 💊 Evidence-based supplementation to rebuild and protect joints
  • 🧘 Movement and lifestyle guidance for long-term joint support
  • 🌿 Adjunct therapies (e.g., acupuncture, physical therapy, regenerative approaches)

By supporting joint structure, reducing inflammation, and addressing root causes, we help you regain strength, mobility, and confidence.


💚 Ready to Rebuild Joint Health?

Together, we can create a tailored plan that reduces pain, improves function, and supports durable joint health—so you can stay active with confidence.


🌱 Join Kaizen Health’s Online Supplement Dispensary

You don’t need to be a Kaizen Health patient to enjoy the benefits of our professional-grade supplement dispensary, powered by Fullscript.

Here’s what you’ll receive:
25% off retail pricing on all supplements
Trusted ingredients from clinically verified brands
Access to science-backed protocols for a variety of health needs

💻 It’s easy and free to join!
Click below to create your account and start receiving 25% off all supplements from trusted, third-party-tested sources.

References
  1. Belcaro, G., Cesarone, M. R., Dugall, M., et al. (2010). Efficacy and safety of Meriva® in osteoarthritis. Alternative Medicine Review, 15(4), 337–344. https://pubmed.ncbi.nlm.nih.gov/21194249/
  2. Belcaro, G., Cesarone, M. R., Errichi, S., et al. (2008). Treatment of osteoarthritis with Pycnogenol (SVOS study). Phytotherapy Research, 22(4), 518–523. https://pubmed.ncbi.nlm.nih.gov/18386255/
  3. Belcaro, G., Cesarone, M. R., Errichi, S., et al. (2008). CRP, free radicals and fibrinogen changes with Pycnogenol. Redox Report, 13(6), 271–276. https://pubmed.ncbi.nlm.nih.gov/19017467/
  4. Blagojevic, M., Jinks, C., Jeffery, A., & Jordan, K. P. (2010). Knee OA risk factors: systematic review/meta-analysis. Osteoarthritis and Cartilage, 18(1), 24–33. https://pubmed.ncbi.nlm.nih.gov/19751691/
  5. Calders, P., & Van Ginckel, A. (2018). Comorbidities and prognosis in hip/knee OA. Seminars in Arthritis and Rheumatism, 47(6), 805–813. https://pubmed.ncbi.nlm.nih.gov/29157670/
  6. Caruso, I., & Pietrogrande, V. (1987). SAMe vs. naproxen vs. placebo in DJD. American Journal of Medicine, 83(5A), 66–71. https://pubmed.ncbi.nlm.nih.gov/3318442/
  7. Cisár, P., Jány, R., Waczulíková, I., et al. (2008). Pycnogenol in knee OA. Phytotherapy Research, 22(8), 1087–1092. https://pubmed.ncbi.nlm.nih.gov/18570266/
  8. Cross, M., Smith, E., Hoy, D., et al. (2014). Global burden of hip and knee OA. Annals of the Rheumatic Diseases, 73(7), 1323–1330. https://pubmed.ncbi.nlm.nih.gov/24553908/
  9. Culvenor, A. G., Øiestad, B. E., Hart, H. F., et al. (2019). MRI OA features in asymptomatic adults. British Journal of Sports Medicine, 53(20), 1268–1278. https://pubmed.ncbi.nlm.nih.gov/29886437/
  10. Di Pierro, F., Rapacioli, G., Di Maio, E. A., et al. (2013). Pain relief: Meriva® vs. nimesulide/acetaminophen. Journal of Pain Research, 6, 201–205. https://pubmed.ncbi.nlm.nih.gov/23526055/
  11. Fransen, M., Agaliotis, M., Nairn, L., et al. (2015). Glucosamine/chondroitin RCT in knee OA. Annals of the Rheumatic Diseases, 74(5), 851–858. https://pubmed.ncbi.nlm.nih.gov/24395557/
  12. Haroyan, A., Mukuchyan, V., Mkrtchyan, N., et al. (2018). Curcumin ± boswellia in OA. BMC Complementary and Alternative Medicine, 18(1), 7. https://pubmed.ncbi.nlm.nih.gov/29316908/
  13. Henrotin, Y., Malaise, M., Wittoek, R., et al. (2019). Bio-optimized Curcuma longa extract for knee OA pain. Arthritis Research & Therapy, 21(1), 179. https://pubmed.ncbi.nlm.nih.gov/31351488/
  14. Hochberg, M. C., Martel-Pelletier, J., Monfort, J., et al. (2016). Chondroitin + glucosamine vs. celecoxib (MOVES). Annals of the Rheumatic Diseases, 75(1), 37–44. https://pubmed.ncbi.nlm.nih.gov/25589511/
  15. Jessberger, S., Högger, P., Genest, F., et al. (2017). Cellular effects of Pycnogenol® in severe OA. BMC Complementary and Alternative Medicine, 17(1), 537. https://pubmed.ncbi.nlm.nih.gov/29246219/
  16. Kim, J., Lee, E. Y., Koh, E.-M., et al. (2009). SAMe vs. nabumetone for knee OA. Clinical Therapeutics, 31(12), 2860–2872. https://pubmed.ncbi.nlm.nih.gov/20110025/
  17. Kimmatkar, N., Thawani, V., Hingorani, L., & Khiyani, R. (2003). Boswellia serrata for knee OA. Phytomedicine, 10(1), 3–7. https://pubmed.ncbi.nlm.nih.gov/12622457/
  18. Kolasinski, S. L., Neogi, T., Hochberg, M. C., et al. (2020). 2019 ACR/AF OA Guideline. Arthritis Care & Research, 72(2), 149–162. https://pubmed.ncbi.nlm.nih.gov/31908149/
  19. Kuptniratsaikul, V., Dajpratham, P., Taechaarpornkul, W., et al. (2014). Curcuma domestica vs. ibuprofen in knee OA. Clinical Interventions in Aging, 9, 451–458. https://pubmed.ncbi.nlm.nih.gov/24672232/
  20. Majeed, M., Majeed, S., Narayanan, N. K., & Nagabhushanam, K. (2019). Novel Boswellia serrata extract in knee OA. Phytotherapy Research, 33(5), 1457–1468. https://pubmed.ncbi.nlm.nih.gov/30838706/
  21. McAlindon, T. E., LaValley, M. P., Gulin, J. P., & Felson, D. T. (2000). Glucosamine/chondroitin meta-analysis. JAMA, 283(11), 1469–1475. https://pubmed.ncbi.nlm.nih.gov/10732937/
  22. Najm, W. I., Reinsch, S., Hoehler, F., et al. (2004). SAMe vs. celecoxib (cross-over). BMC Musculoskeletal Disorders, 5, 6. https://pubmed.ncbi.nlm.nih.gov/15102339/
  23. Pavelká, K., Gatterová, J., Olejarová, M., et al. (2002). Glucosamine sulfate delays knee OA progression. Archives of Internal Medicine, 162(18), 2113–2123. https://pubmed.ncbi.nlm.nih.gov/12374520/
  24. Srivastava, S., Saksena, A. K., Khattri, S., et al. (2016). Curcuma longa lowers inflammatory/oxidative biomarkers in knee OA. Inflammopharmacology, 24(6), 377–388. https://pubmed.ncbi.nlm.nih.gov/27761693/
  25. Wallace, I. J., Worthington, S., Felson, D. T., et al. (2017). Knee OA prevalence has doubled since mid-20th century. PNAS, 114(35), 9332–9336. https://pubmed.ncbi.nlm.nih.gov/28808025/
  26. Yu, G., Xiang, W., Zhang, T., et al. (2020). Effectiveness of Boswellia for OA: systematic review/meta-analysis. BMC Complementary Medicine and Therapies, 20(1), 225. https://pubmed.ncbi.nlm.nih.gov/32680575/
  27. Zhu, X., Wu, D., Sang, L., et al. (2018). Comparative effectiveness: glucosamine, chondroitin, acetaminophen, celecoxib. Clinical and Experimental Rheumatology, 36(4), 595–602. https://pubmed.ncbi.nlm.nih.gov/29465368/

Dr. Steven Baum, MD

steve kaizen
NPI Number

1205339090

Medical Licenses

Arizona, California, Idaho, Montana, Nevada, Ohio, Utah, Washington, Wyoming

Years Practicing

6 Years

Certifications

American Board of Family Medicine
American Board of Obesity Medicine
National Academy of Sports Medicine

Education

B.S. in Exercise & Sport Science – University of Utah
M.H.A. – Louisiana State University
M.D. – The Ohio State University College of Medicine

Related Services

Share With Others

Service Categories

View All Services

weight scale

Medical Weight Loss

Learn more

nutrition

Dietary Analysis & Coaching

Learn more

gender sign

Medical Hormone Optimization

Learn more

dna strand

Nutraceutical Dispensary

Learn more

lab test

Lab Testing

Learn more

prescription

Sick Visits

Learn more

membership

Concierge Medicine

Learn more

pillars

Pillars of Health

Learn more

Our Client Experience

115+ Reviews

Hear from Kaizen Clients: